Iodixanol Versus Iopamidol in Patients Undergoing Contrast-Enhanced Computed Tomographic Imaging of Abdomen/Pelvis

PHASE4CompletedINTERVENTIONAL
Enrollment

304

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

October 31, 2011

Study Completion Date

February 29, 2012

Conditions
Patient Comfort and Safety
Interventions
DRUG

Iodixanol

Iodixanol 320 mg I/mL as a single iv. administration.

DRUG

Iopamidol

Comparator agent iopamidol (Isovue) 370 mg I/mL as a single iv. administration.

Trial Locations (1)

08540

GE Healthcare, Princeton

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

i3 Statprobe

INDUSTRY

lead

GE Healthcare

INDUSTRY